These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1020 related items for PubMed ID: 17148851
1. The effect of blood glucose levels on hemorheological parameters, platelet activation and aggregation in oral glucose tolerance tests. Koltai K, Feher G, Kesmarky G, Keszthelyi Z, Czopf L, Toth K. Clin Hemorheol Microcirc; 2006; 35(4):517-25. PubMed ID: 17148851 [Abstract] [Full Text] [Related]
2. Effect of parenteral or oral vinpocetine on the hemorheological parameters of patients with chronic cerebrovascular diseases. Feher G, Koltai K, Kesmarky G, Horvath B, Toth K, Komoly S, Szapary L. Phytomedicine; 2009 Mar; 16(2-3):111-7. PubMed ID: 19135345 [Abstract] [Full Text] [Related]
4. Serum high-molecular weight adiponectin decreases abruptly after an oral glucose load in subjects with normal glucose tolerance or impaired fasting glucose, but not those with impaired glucose tolerance or diabetes mellitus. Ozeki N, Hara K, Yatsuka C, Nakano T, Matsumoto S, Suetsugu M, Nakamachi T, Takebayashi K, Inukai T, Haruki K, Aso Y. Metabolism; 2009 Oct; 58(10):1470-6. PubMed ID: 19592051 [Abstract] [Full Text] [Related]
5. Multivariate analysis of relationships between insulin sensitivity and blood rheology: is plasma viscosity a marker of insulin resistance? Pérez-Martin A, Dumortier M, Pierrisnard E, Raynaud E, Mercier J, Brun JF. Clin Hemorheol Microcirc; 2001 Oct; 25(3-4):91-103. PubMed ID: 11847412 [Abstract] [Full Text] [Related]
6. Follow-up of hemorheological parameters and platelet aggregation in patients with acute coronary syndromes. Marton Z, Horvath B, Alexy T, Kesmarky G, Gyevnar Z, Czopf L, Habon T, Kovacs L, Papp E, Mezey B, Roth E, Juricskay I, Toth K. Clin Hemorheol Microcirc; 2003 Oct; 29(2):81-94. PubMed ID: 14610303 [Abstract] [Full Text] [Related]
7. Improvement of hemorheological abnormalities in alcoholics by an oral antioxidant. Marotta F, Safran P, Tajiri H, Princess G, Anzulovic H, Idéo GM, Rouge A, Seal MG, Idéo G. Hepatogastroenterology; 2001 Oct; 48(38):511-7. PubMed ID: 11379344 [Abstract] [Full Text] [Related]
8. Hemorheological aspects of the metabolic syndrome: markers of insulin resistance, obesity or hyperinsulinemia? Brun JF, Aloulou I, Varlet-Marie E. Clin Hemorheol Microcirc; 2004 Oct; 30(3-4):203-9. PubMed ID: 15258344 [Abstract] [Full Text] [Related]
9. Hemorheology, plasma protein composition and von Willebrand factor in type I diabetic nephropathy. Zimmermann J, Schramm L, Wanner C, Mulzer E, Henrich HA, Langer R, Heidbreder E. Clin Nephrol; 1996 Oct; 46(4):230-6. PubMed ID: 8905207 [Abstract] [Full Text] [Related]
10. Do hemorheological alterations play any role in the development of thrombotic events in Behçet's disease? Vayá A, Ricart J, Todolí J, Micó L, Contreras T, Aznar J. Clin Hemorheol Microcirc; 2004 Oct; 30(3-4):411-4. PubMed ID: 15258375 [Abstract] [Full Text] [Related]
11. Rheological profile in severe and morbid obesity. Preliminary results. Solá E, Vayá A, Contreras T, Falcó C, Corella D, Hernández A, Aznar J. Clin Hemorheol Microcirc; 2004 Oct; 30(3-4):415-8. PubMed ID: 15258376 [Abstract] [Full Text] [Related]
12. Diabetes and impaired glucose tolerance prevalences in Turkish patients with impaired fasting glucose. Tutuncuoğlu P, Saraç F, Saygili F, Ozgen AG, Yilmaz C, Tüzün M. Acta Diabetol; 2008 Sep; 45(3):151-6. PubMed ID: 18496644 [Abstract] [Full Text] [Related]
13. Effects of cyclodextrins on RBC aggregation and blood viscosity. Toyama Y, Pais E, Meiselman HJ, Alexy T. Clin Hemorheol Microcirc; 2007 Sep; 36(2):173-80. PubMed ID: 17325441 [Abstract] [Full Text] [Related]
14. The antioxidant alpha-lipoic acid improves endothelial dysfunction induced by acute hyperglycaemia during OGTT in impaired glucose tolerance. Xiang GD, Sun HL, Zhao LS, Hou J, Yue L, Xu L. Clin Endocrinol (Oxf); 2008 May; 68(5):716-23. PubMed ID: 18070144 [Abstract] [Full Text] [Related]
15. Evaluation of hemorheological risk factor profile in plasmacytoma patients. Ramakrishnan S, Grebe R, Singh M, Schmid-Schönbein H. Clin Hemorheol Microcirc; 1999 May; 20(1):11-9. PubMed ID: 11185678 [Abstract] [Full Text] [Related]
16. Hemorheological disturbances in patients with chronic cerebrovascular diseases. Szapary L, Horvath B, Marton Z, Alexy T, Demeter N, Szots M, Klabuzai A, Kesmarky G, Juricskay I, Gaal V, Czopf J, Toth K. Clin Hemorheol Microcirc; 2004 May; 31(1):1-9. PubMed ID: 15272148 [Abstract] [Full Text] [Related]
17. Rheological changes in diabetic microangiopathy. Negrean V, Suciu I, Sâmpelean D, Cozma A. Rom J Intern Med; 2004 May; 42(2):407-13. PubMed ID: 15529630 [Abstract] [Full Text] [Related]
18. [Effects of cardiovascular risk factors on hemorheologic parameters in cerebrovascular patients]. Szapáry L, Szóts M, Horváth B, Márton Z, Alexy T, Késmárky G, Juricskay I, Nagy F, Gaál V, Pálfi A, Koltai K, Tóth K. Orv Hetil; 2003 Jun 01; 144(22):1085-90. PubMed ID: 12847818 [Abstract] [Full Text] [Related]
19. Platelet aggregation and metabolic control are not affected by calcium antagonist treatment in type II diabetes mellitus. Klauser R, Speiser P, Gisinger C, Schernthaner G, Prager R. J Cardiovasc Pharmacol; 1990 Jun 01; 15 Suppl 1():S93-6. PubMed ID: 1695314 [Abstract] [Full Text] [Related]
20. The effect of aspirin on hemorheological parameters of patients with diabetic retinopathy. Vekasi J, Koltai K, Gaal V, Toth A, Juricskay I, Kesmarky G. Clin Hemorheol Microcirc; 2008 Jun 01; 39(1-4):385-9. PubMed ID: 18503149 [Abstract] [Full Text] [Related] Page: [Next] [New Search]